Global Research & Development

Research and development activities are the heart of the pharmaceutical industry’s value creation. R&D fuels the product pipeline but takes its fair share of the expense side of the balance sheet. It is estimated that bringing a successful drug to market from discovery through development to market launch costs well in excess of US$1 billion.

Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.